Octreotide Acetate
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12091 publications
A 13-Year-Old Girl with Congenital Hyperinsulinemic Hypoglycemia Due to an ABCC8 Mutation and Recent Onset of Diabetes Mellitus: A Case Report and Literature Review.
Journal: Journal of clinical research in pediatric endocrinology
Published: April 14, 2026
A case of recurrent liver metastasis from a rectal neuroendocrine tumor 9 years after endoscopic resection
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: April 12, 2026
Primary Intestinal Lymphangiectasia Presenting as Recurrent Chylous Ascites: A Rare Case.
Journal: Journal of investigative medicine high impact case reports
Published: April 07, 2026
DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.
Journal: ACS nano
Published: April 01, 2026
Optimal timing for octreotide administration in adult patients with chylothorax: A scoping review
Journal: Nutricion hospitalaria
Published: March 25, 2026
Analysis of stimulating factors for serum copeptin based on liquid chromatography-tandem mass spectrometry
Journal: Se pu = Chinese journal of chromatography
Published: March 12, 2026
Effective Thoracic Duct Ligation at T9 for Postoperative Chylothorax: A Case Report.
Journal: Cureus
Published: March 02, 2026
Medical Versus Surgical/Endoscopic Management of Malignant Bowel Obstruction in Patients With End-Stage Gynecologic Cancer: A 12-Year Single-Center Experience.
Journal: Cureus
Published: February 24, 2026
Midodrine Monotherapy in Refractory Hepatorenal Syndrome-Acute Kidney Injury: A Case Report.
Journal: Cureus
Published: February 24, 2026
Iodixanol-induced acute kidney injury and multi-organ complications via alternative excretion: A case report and mechanism exploration.
Journal: International journal of clinical pharmacology and therapeutics
Published: February 22, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 20, 2026
Last Updated: 04/28/2026